| Dr Noa Biran, MD | |
|
92 2nd St, Hackensack, NJ 07601-2191 | |
| (551) 996-8704 | |
| (551) 996-0582 |
| Full Name | Dr Noa Biran |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 16 Years |
| Location | 92 2nd St, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023277910 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0000X | Internal Medicine - Hematology | 25MA09466300 (New Jersey) | Secondary |
| 207RX0202X | Internal Medicine - Medical Oncology | 25MA09466300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Southern Ocean Medical Center | Manahawkin, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Hackensackumc Mountainside | Montclair, NJ | Hospital |
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Cancer Care Associates Llc | 5294710091 | 104 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.
Scientists at Johns Hopkins have found that 1 percent to 2 percent of those infected with HIV in Baltimore apparently suppress the virus to nearly undetectable levels on their own, confounding public health efforts to accurately monitor the pandemic's spread, now in its 20th year.
A wireless, battery-less pacemaker that can be implanted directly into a patient's heart is being introduced by researchers from Rice University and their colleagues at the Texas Heart Institute at the IEEE's International Microwave Symposium in Honolulu June 4-9.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
The Ohio State University is hosting the inaugural Building Healthy Academic Communities National Summit on April 22-23 in an effort to improve health and wellness outcomes among the 31.2 million students, faculty and staff in US higher education.
› Verified 8 days ago
| Entity Name | Regional Cancer Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801850243 PECOS PAC ID: 5294710091 Enrollment ID: O20040623001494 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.
Scientists at Johns Hopkins have found that 1 percent to 2 percent of those infected with HIV in Baltimore apparently suppress the virus to nearly undetectable levels on their own, confounding public health efforts to accurately monitor the pandemic's spread, now in its 20th year.
A wireless, battery-less pacemaker that can be implanted directly into a patient's heart is being introduced by researchers from Rice University and their colleagues at the Texas Heart Institute at the IEEE's International Microwave Symposium in Honolulu June 4-9.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
The Ohio State University is hosting the inaugural Building Healthy Academic Communities National Summit on April 22-23 in an effort to improve health and wellness outcomes among the 31.2 million students, faculty and staff in US higher education.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Noa Biran, MD 92 2nd St, Hackensack, NJ 07601-2191 Ph: () - | Dr Noa Biran, MD 92 2nd St, Hackensack, NJ 07601-2191 Ph: (551) 996-8704 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.
Scientists at Johns Hopkins have found that 1 percent to 2 percent of those infected with HIV in Baltimore apparently suppress the virus to nearly undetectable levels on their own, confounding public health efforts to accurately monitor the pandemic's spread, now in its 20th year.
A wireless, battery-less pacemaker that can be implanted directly into a patient's heart is being introduced by researchers from Rice University and their colleagues at the Texas Heart Institute at the IEEE's International Microwave Symposium in Honolulu June 4-9.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
The Ohio State University is hosting the inaugural Building Healthy Academic Communities National Summit on April 22-23 in an effort to improve health and wellness outcomes among the 31.2 million students, faculty and staff in US higher education.
› Verified 8 days ago
Dr. Sean Shabbir Sadikot, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Naresh Chanderi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |